Sign in

James Bales

Research Analyst at Morgan Stanley

James Bales is an Equities Research Analyst at Morgan Stanley, specializing in coverage of general sectors across the Australian, German, and US markets. He covers 28 stocks including notable companies such as Life360, and has issued over 420 ratings with a track record that includes a 45% success rate and an average return per rating of 0.0% on TipRanks. Bales has been publishing analyst ratings since 2021 at Morgan Stanley, and prior experience includes equities research roles, though his career prior to Morgan Stanley is not comprehensively detailed publicly. He is recognized for his market insights, particularly in the general sector, but specific details on professional credentials like FINRA registrations are not publicly available.

James Bales's questions to Life360 (LIF) leadership

James Bales's questions to Life360 (LIF) leadership • Q2 2025

Question

James Bales of Morgan Stanley inquired about the go-to-market strategy for Life360's upcoming pet tracking product, asking for details on the launch timing, target countries, sales channels, hardware pricing, and any potential production issues related to tariffs.

Answer

CEO Lauren Antonoff confirmed that the pet tracker launch is on schedule for the holiday season. However, she stated that specific details regarding pricing and market rollout are being withheld for now to ensure a successful launch event.

Ask Fintool Equity Research AI

James Bales's questions to LIFX leadership

James Bales's questions to LIFX leadership • Q1 2024

Question

Inquired about the unexpected strength in subscriber growth compared to previous cautious guidance, the expected seasonality for the rest of the year, the strategy for the new advertising business including platform integrations and deal mix, and the size of the team working on the ad product.

Answer

Executives attributed strong growth to organic demographic tailwinds and international focus, with momentum continuing into April. The advertising strategy involves a multi-year build-out of a proprietary tech stack, not just plugging into platforms, to enable various deal types. The team working on ads is currently small and integrated into other functions, with investment planned to scale alongside revenue.

Ask Fintool Equity Research AI